Retigraph 20% Injection
By Retigraph
Rx
3ml Injection in a Vial

Composition
Fluorescein(0.2)

Manufacturer - Sunways India Pvt Ltd
1002-1003, 10th Floor, Windfall, Sahar Plaza, J.B.Nagar, Andheri-Kurla Road, Andheri (East), Mumbai-400059. Maharashtra, India.

Expires on or after
October, 2025

liver
There is limited information about the safety of using Retigraph 20% Injection in patients with liver disease. It is important to consult your doctor before using this injection if you have any liver-related issues. Your healthcare provider will be able to assess your specific situation and provide guidance on the safety and appropriateness of using Retigraph 20% Injection for you.

kidney
Limited information exists on using Retigraph 20% Injection in kidney disease patients. It is advisable to consult your doctor before use.

alcohol
It is not confirmed if alcohol is safe to consume with Retigraph 20% Injection. Consult your doctor for advice on alcohol use.

driving
When using Retigraph 20% Injection, refrain from driving if you have symptoms that impact your focus and reaction time. It is uncertain if this medication affects driving ability.

pregnancy
Retigraph 20% Injection may not be safe to use during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it. Please consult your doctor.

breastfeeding
Retigraph 20% Injection is considered safe to use while breastfeeding. Human data indicates minimal risk to the baby.
Habit Forming | No |
Chemical Class | Xanthenes Derivative |
Therapeutic Class | - |
Action Class | Dye-Ocular |
₹87.4
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025